Strategic Growth Schivo recently expanded through the acquisition of Mecaplast SA, signaling a growth trajectory and increased capabilities in high-precision plastics, metals, and ceramics for medical devices. This presents cross-selling opportunities to integrate Mecaplast’s advanced molding and materials expertise with Schivo’s existing end-to-end manufacturing services.

Molding Leadership With the appointment of Jean-Marc Jaccottet as President of Molding Technologies, Schivo is prioritizing R&D and capacity expansion in advanced molding solutions. This creates opening for partnerships on development projects needing rapid scalability and innovative molding technologies.

Full-Service Partner Schivo positions itself as a natural extension of client development teams, handling concept to commercial launch, including prototyping and finished devices. Sales opportunities exist with medical device companies seeking integrated manufacturing, rapid prototyping, and supply chain continuity under one provider.

Regulatory Readiness Operating under AS9100 and offering vertically integrated manufacturing, Schivo’s quality and regulatory compliance framework can be leveraged to attract clients aiming to accelerate time-to-market for regulated medical devices, including mass spectrometry and minimally invasive surgery tooling.

Global Capabilities Schivo’s international footprint and recent acquisitions position it to support multinational device programs and complex global supply chains. Target customers include healthcare OEMs seeking scalable, compliant manufacturing partners with breadth in plastics, metals, ceramics, and precision machining.